1 Introduction

The Cancer Genetics and Epigenetics (CGE) Journal has been founded since 2014 year. With a scope that spans the areas of Cancer Genetics and Cancer Epigenetics, the journal is aimed to publish all works in the areas that with quality and originality.

 

2 Aims and Scope

The CGE Journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention research papers describing original researches and reviews of broad general interest in Cancer - a particular emphasis is placed on Molecular Genetics and Epigenetics.

 

The journal encourages and publishes articles that report novel findings of wide biological significance in the areas of:

Cancer

Computational Cancer Genomics

Molecular Network in Cancer

Cancer Epigenomics

Radiation biology

Molecular pathology

Hormones and cancer

Cancer Genomics and targets

Expression patterns in Cancer cells and tumors

Experimental therapeutics

Molecular and cellular pathobiolog

Tumor and stem cell biology

Prevention and epidemiology

Ageing

Autophagy

Cell Death

 

The CGE Journal has a fair and transparent process to rapidly publish important science.

 

3 Publication Mode

We are following the Open Access publishing model. All papers published in this journal are licensed to all users under the terms of Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and recproduction in any media, provided the original work is properly cited (see MedSci Publisher Open Access Policy).

 

Manuscripts must be submitted by MedSci Publisher online Manuscripts Handling System, or send your manuscript directly to the submission email of Cancer Genetics and Epigenetics: edit@cge.medscipublisher.com. For details please see Instructions for Authors.

 

4 Publication and Peer-review Process

4.1 Similarity check

All submissions will be subjected to CrossRef's plagiarism check by CrossCheck. Only those with no any similarity compared in the CrossCheck database can be proceeded for peer review. Plagarism check in this journal is solely for the purpose of submission’s language arts and does not imply any plagiarism or forging existed.

 

4.2 Peer-review

Scientists in the world are invited to be as peer reviewer in this journal. All submission will be automatically transferred online to the reviewers by Manuscript Handling System in the MedSci Publisher prior to CrossRef's plagiarism check by CrossCheck.

 

4.3 Online Publication

There are much more advantages for online publishing, including:

** Peer review quickly and professionally

** Anti- Plagiarism by CrossCheck

** Publish on line immediately upon acceptance

** Deposit permanently and track easily

** Open Access under Creative Common licences

** Disseminate multilingual possible

 

4.4 Indexing and Archiving

All articles published in Cancer Genetics and Epigenetics will be deposited in CrossRef with the DOI (Digital Object Identifer) identity. For details please see Instructions for Submission.

 

5 Publication Period

Cancer Genetics and Epigenetics promises to offer much faster publication schedules. Normally, it takes four or six weeks depand on the speed of peer review. Using the recommended manuscript preparation formats will largely speed up the paper procedures and shorten the periods. Research articles will be published electronically in provisional PDF immediately upon acceptance. A fully HTMLweb version and PDF download version will be available within six weeks after acceptance.

 

6 Citing articles in Cancer Genetics and Epigenetics

Articles in this journal should be recommended to follow regular citation rules. There is an exception for unique article series and DOI instead of the page number.

 

The preferred citation:

Authors’ name, Publishing year, Article title, Journal name, Volume, Article number (DOI)